Jeffrey Schlom

Also affiliated with National Cancer Institute, Center for Cancer Research

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients

(2023)10.1158/1078-0432.22442447

Top 100%

0DataRank

Top 100%0 citations

Alvin Wei Tian Ng, Kwong-Yok Tsang, Theresa Ferrara, Jeffrey Schlom, James L. Gulley +2 more

Papers

Driven by 103 papers — median percentile 0. Top paper: “Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies”.

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001395

N/A

3.6DataRank · unranked

159 citations

Margaret E. Gatti‐Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward F. McClay +18 more

Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication

Journal of Clinical Investigation(2022)10.1172/jci155148

N/A

2.9DataRank · unranked

119 citations

Paul L. Chariou, Sofia R. Gameiro, Haiyan Qin, Masafumi Iida, Kristen Fousek +7 more

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

eLife(2020)10.7554/elife.54854

N/A

2.1DataRank · unranked

59 citations

Sarah Greene, Jay Friedman, Paúl E. Clavijo, Carter Van Waes, Kellsye P. Fabian +9 more

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer

Journal of Clinical Investigation(2022)10.1172/jci161400

N/A

1.9DataRank · unranked

79 citations

Jay Friedman, Yvette Robbins, Cem Sievers, Xinping Yang, Wiem Lassoued +17 more

Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001691

N/A

1.8DataRank · unranked

54 citations

Michelle R. Padget, Rika Fujii, Jeffrey Schlom, James W. Hodge, Kellsye P. Fabian

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000655

N/A

1.8DataRank · unranked

77 citations

Jennifer L. Marté, Renee N. Donahue, Beatriz Walter-Rodriguez, Christopher R. Heery, Seth M. Steinberg +13 more

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003238

N/A

1.2DataRank · unranked

41 citations

Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai, Angie Schwab +16 more

PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00368-0

N/A

0.935DataRank · unranked

23 citations

Janet Valdez, Scott Napier, Meg Kenyon, Erin Ferraro, Melissa Wheatley +9 more

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer

Frontiers in Endocrinology(2020)10.3389/fendo.2020.00490

N/A

0.888DataRank · unranked

23 citations

Renee N. Donahue, Jennifer L. Marté, Ann W. Gramza, Marijo Bilušić, Myrna Rauckhorst +7 more

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00492-y

N/A

0.873DataRank · unranked

22 citations

Nicole J. Toney, Renee N. Donahue, Susan Wróblewski, Matthew R. Zibelman, Pooja Ghatalia +9 more

Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003113

N/A

0.811DataRank · unranked

16 citations

Jay Friedman, Paúl E. Clavijo, Cem Sievers, Ke Bai, Renee N. Donahue +8 more

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005813

N/A

0.810DataRank · unranked

25 citations

Jean‐Laurent Deville, Mario Sznol, Alain Ravaud, Marco Maruzzo, Russell K. Pachynski +14 more

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008480

N/A

0.612DataRank · unranked

19 citations

Houssein Abdul Sater, Osama E. Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L. Marté +13 more

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyac244

N/A

0.588DataRank · unranked

16 citations

Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić +14 more

Phase 1 trial of CV301 in combination with anti‐PD‐1 therapy in nonsquamous non‐small cell lung cancer

International Journal of Cancer(2022)10.1002/ijc.34267

N/A

0.564DataRank · unranked

11 citations

Jhanelle E. Gray, Siddhartha Devarakonda, Ruemu Birhiray, Borys Korchin, Erika Menius +4 more

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007386

N/A

0.402DataRank · unranked

9 citations

Kristen Fousek, Lucas A. Horn, Shantel Angstadt, Haiyan Qin, Duane H. Hamilton +3 more

Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine

Journal of Immunotherapy(2023)10.1097/cji.0000000000000459

N/A

0.261DataRank · unranked

4 citations

Jason M. Redman, Fatima Karzai, William L. Dahut, Lisa M. Cordes, Farhad Fakhrejahani +5 more

Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection

The Oncologist(2025)10.1093/oncolo/oyaf006

N/A

0.251DataRank · unranked

4 citations

Renee N. Donahue, Seth J Steinberg, Jennifer L. Marté, Lisa M. Cordes, Charalampos S. Floudas +7 more

NHS-IL12, a Tumor-Targeting Immunocytokine

ImmunoTargets and Therapy(2021)10.2147/itt.s306150

N/A

0DataRank · unranked

46 citations

Y. Maurice Morillon, Jeffrey Schlom, John W. Greiner

Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009

JCI Insight(2021)10.1172/jci.insight.141912

N/A

0DataRank · unranked

24 citations

Claire Smalley, Y. Maurice Morillon, Nicholas Roller, Lisa K. Poppe, Douglas E. Brough +4 more

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.581801

N/A

0DataRank · unranked

22 citations

Sofia R. Gameiro, Yohei Ozawa, Karin M. Knudson, Kristin C. Hicks, Claudia Palena +10 more

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis

npj Vaccines(2021)10.1038/s41541-021-00348-x

N/A

0DataRank · unranked

12 citations

Simon Metenou, Douglas E. Brough, Helen Sabzevari, Ke Bai, Caroline Jochéms +3 more

Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002087

N/A

0DataRank · unranked

10 citations

Jennifer L. Marté, Meghali Goswami, Nicole J. Toney, Yo-Ting Tsai, James L. Gulley +2 more

Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa

OncoImmunology(2021)10.1080/2162402x.2021.1915561

N/A

0DataRank · unranked

6 citations

Kristin C. Hicks, Christine M. Minnar, Karin M. Knudson, Jeffrey Schlom, Sofia R. Gameiro +1 more

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

Journal of Cancer Prevention(2021)10.15430/jcp.2021.26.4.309

N/A

0DataRank · unranked

1 citations

Roderick H. Dashwood, Sally E. Dickinson, Mary L. Disis, Elizabeth M. Jaffee, Bryon D. Johnson +10 more

Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2501

N/A

0DataRank · unranked

20 citations

Charalampos S. Floudas, Houssein Abdul Sater, Michell Manu, Elizabeth Lamping, Deneise C Francis +15 more

A phase I study of bintrafusp alfa (M7824) and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in adults with metastatic non-prostate genitourinary malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4599

N/A

0DataRank · unranked

4 citations

Daniel M. Girardi, Lisa M. Cordes, Lisa Ley, Marissa Mallek, Olena Sierra Ortiz +15 more

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5096

N/A

0DataRank · unranked

3 citations

Marijo Bilušić, Fatima Karzai, Lisa M. Cordes, Julius Strauss, Houssein Abdul Sater +10 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

582 Immune correlates from QuEST1 in men with castration-resistant prostate cancer

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.582

N/A

0DataRank · unranked

2 citations

Yo-Ting Tsai, Jason M. Redman, James L. Gulley, Jeffrey Schlom, Renee N. Donahue +1 more

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2617

N/A

0DataRank · unranked

0 citations

Katherine Lee-Wisdom, Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Claudia Palena +14 more

6 Immune correlates of clinical benefit in patients with HPV-associated malignancies treated with bintrafusp alfa

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-sitc2021.006

N/A

0DataRank · unranked

0 citations

Renee N. Donahue, Nicole J. Toney, Julius Strauss, James L. Gulley, Jeffrey Schlom +1 more

727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.727

N/A

0DataRank · unranked

0 citations

Kristen Fousek, Lucas A. Horn, Haiyan Qin, Jeffrey Schlom, Claudia Palena +1 more

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004561

N/A

0DataRank · unranked

48 citations

Paul L. Chariou, Lucas A. Horn, Kristin C. Hicks, Claudia Palena, Jeffrey Schlom +2 more

Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status

Experimental Biology and Medicine(2022)10.1177/15353702221089910

N/A

0DataRank · unranked

31 citations

Julius Strauss, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.008

N/A

0DataRank · unranked

24 citations

Lucas A. Horn, Haiyan Qin, Madeline Dahut, Masafumi Iida, Dan Yacubovich +5 more

Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity

JCI Insight(2022)10.1172/jci.insight.157448

N/A

0DataRank · unranked

16 citations

Yvette Robbins, Xinping Yang, Wojciech K. Mydlarz, Anastasia L. Sowers, James B. Mitchell +6 more

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors

The Oncologist(2022)10.1093/oncolo/oyac026

N/A

0DataRank · unranked

4 citations

Madison Ballman, Haobin Chen, Shannon Swift, Meredith J. McAdams, Yo-Ting Tsai +8 more

Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2518

N/A

0DataRank · unranked

11 citations

Charalampos S. Floudas, Danielle M. Pastor, Michell Manu, Elizabeth Lamping, Deneise C Francis +11 more

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.127

N/A

0DataRank · unranked

4 citations

Ravi A. Madan, Nicole J. Toney, Renee N. Donahue, Margaret E. Gatti‐Mays, Julius Strauss +12 more

Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.093

N/A

0DataRank · unranked

4 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Evaluating the optimal sequence of immunotherapy and docetaxel in men with metastatic castration-sensitive prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.130

N/A

0DataRank · unranked

3 citations

Mohammad Atiq, Renee N. Donahue, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +11 more

Contrasting autoimmune and treatment effects reveals baseline set points of immune toxicity following checkpoint inhibitor treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.05.494592

N/A

0DataRank · unranked

3 citations

Matthew P. Mulè, Andrew J. Martins, Iago Pinal‐Fernandez, Renee N. Donahue, Jinguo Chen +6 more

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17033

N/A

0DataRank · unranked

3 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Immunotherapy to prevent progression on active surveillance study (IPASS): A phase II, randomized, double-blind, controlled trial of PROSTVAC in prostate cancer patients who are candidates for active surveillance.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.249

N/A

0DataRank · unranked

2 citations

Peter A. Pinto, Howard L. Parnes, Christian P. Pavlovich, Edward Uchio, Mike Nguyen +13 more

Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer

Cancer Cell(2023)10.1016/j.ccell.2023.03.014

N/A

0DataRank · unranked

71 citations

Marco Craveiro, Jay Friedman, Yvette Robbins, Xinping Yang, Ke Bai +8 more

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03496-2

N/A

0DataRank · unranked

39 citations

Jeffrey Schlom, Duane H. Hamilton, María del Mar Maldonado

The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis

Science Translational Medicine(2023)10.1126/scitranslmed.adj0740

N/A

0DataRank · unranked

26 citations

Ke Bai, Cem Sievers, Yvette Robbins, Jay Friedman, Xinping Yang +10 more

A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity

Science Translational Medicine(2023)10.1126/scitranslmed.adi0258

N/A

0DataRank · unranked

23 citations

Renee N. Donahue, Madan Katragadda, Jessica Lowry, Wei Huang, Karunya Srinivasan +15 more

Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies

Cells(2023)10.3390/cells12121611

N/A

0DataRank · unranked

20 citations

Christine M. Minnar, Patrick Soon‐Shiong, Jeffrey Schlom, Sofia R. Gameiro, Grace Lui

Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02802-1

N/A

0DataRank · unranked

12 citations

Jeffrey Schlom, Renee N. Donahue, Nicole J. Toney

Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12

International Immunopharmacology(2023)10.1016/j.intimp.2023.109736

N/A

0DataRank · unranked

9 citations

Margaret E. Gatti‐Mays, Nicholas Tschernia, Julius Strauss, James L. Gulley, Jeffrey Schlom +2 more

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03459-7

N/A

0DataRank · unranked

7 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Kristen Solocinski, Paul L. Chariou, Duane H. Hamilton +6 more

AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors

Mediastinum(2023)10.21037/med-23-ab016

N/A

0DataRank · unranked

3 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +14 more

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies

Oncotarget(2023)10.18632/oncotarget.28487

N/A

0DataRank · unranked

1 citations

Jeffrey Schlom, Renee N. Donahue, Meghali Goswami

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

Phase II evaluation of combination immunotherapy with CV301, N-803, bintrafusp alfa, and M9241 in patients with advanced small bowel and colorectal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.116

N/A

0DataRank · unranked

4 citations

Jason M. Redman, Charalampos S. Floudas, Elizabeth Lamping, Deneise C Francis, Lisa M. Cordes +5 more

781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0781

N/A

0DataRank · unranked

2 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +11 more

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.377

N/A

0DataRank · unranked

1 citations

Nicole J. Toney, Renee N. Donahue, Fatima Karzai, Ravi A. Madan, Jeffrey Schlom +8 more

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps6116

N/A

0DataRank · unranked

1 citations

Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, Jenn Marte +7 more

A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4571

N/A

0DataRank · unranked

1 citations

Scot A. Niglio, Elias Chandran, Giovanni Maria Iannantuono, Salah Boudjadi, Rouf Banday +15 more

Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.207

N/A

0DataRank · unranked

0 citations

Meghali Goswami, Renee N. Donahue, Mohammad Atiq, Fatima Karzai, Marijo Bilušić +13 more

Data from A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

(2023)10.1158/1078-0432.c.6519708.v1

N/A

0DataRank · unranked

0 citations

Kwong-Yok Tsang, Ravi A. Madan, Ngar‐Yee Huen, Diane J. Poole, Caroline Jochéms +12 more

Data from A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

(2023)10.1158/1078-0432.c.6519708

N/A

0DataRank · unranked

0 citations

Kwong-Yok Tsang, Ravi A. Madan, Ngar‐Yee Huen, Diane J. Poole, Caroline Jochéms +12 more

Data from The Antitumor and Immunoadjuvant Effects of IFN-α in Combination with Recombinant Poxvirus Vaccines

(2023)10.1158/1078-0432.c.6517465

N/A

0DataRank · unranked

0 citations

Connie J. Rogers, David A. Zaharoff, Daniel Canter, Jeffrey Schlom, John W. Greiner +1 more

Data from Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

(2023)10.1158/1078-0432.c.6517102.v1

N/A

0DataRank · unranked

0 citations

Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole +11 more

Supplementary Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients

(2023)10.1158/1078-0432.22442447

Top 100%

0DataRank

Top 100%0 citations

Alvin Wei Tian Ng, Kwong-Yok Tsang, Theresa Ferrara, Jeffrey Schlom, James L. Gulley +2 more

Supplementary Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22442447.v1

Top 100%

0DataRank

Top 100%0 citations

Alvin Wei Tian Ng, Kwong-Yok Tsang, Theresa Ferrara, Jeffrey Schlom, James L. Gulley +2 more

Data from Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

(2023)10.1158/2326-6066.c.6550240

N/A

0DataRank · unranked

0 citations

Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii +4 more

Data from Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

(2023)10.1158/2326-6066.c.6548671.v1

N/A

0DataRank · unranked

0 citations

Caroline Jochéms, Massimo Fantini, Christopher R. Heery, James L. Gulley, Kwong Y. Tsang +2 more

Data from Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

(2023)10.1158/2326-6066.c.6550240.v1

N/A

0DataRank · unranked

0 citations

Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii +4 more

Mass cytometry immune profiling to detect signatures of clinical activity of bintrafusp alfa (BA) in patients with advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21016

N/A

0DataRank · unranked

0 citations

Carlos Medina, Connor P. Healy, Renee N. Donahue, Natalia Sigal, Elizabeth Enrico +8 more

1413 Immunogenicity of SARS-CoV-2 mRNA vaccines in individuals with thymic epithelial tumors

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1413

N/A

0DataRank · unranked

0 citations

Hanna S Loving, Shannon Swift, Meredith J. McAdams, Chen Zhao, Éva Szabó +8 more

Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-02969-1

N/A

0DataRank · unranked

46 citations

Jeffrey Schlom, Renee N. Donahue, Yo-Ting Tsai

Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine

Frontiers in Oncology(2024)10.3389/fonc.2023.1321318

N/A

0DataRank · unranked

26 citations

Grace Lui, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro, Christine M. Minnar

Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009595

N/A

0DataRank · unranked

5 citations

Renee N. Donahue, Claudia Palena, Sofia R. Gameiro, James W. Hodge, Duane H. Hamilton +2 more

1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1712

N/A

0DataRank · unranked

3 citations

Ravi A. Madan, Fatima Karzai, Lisa M. Cordes, Jenn Marte, N. Williams +9 more

TGF-β neutralization attenuates tumor residency of activated T cells to enhance systemic immunity in mice

iScience(2024)10.1016/j.isci.2024.110520

N/A

0DataRank · unranked

6 citations

Cem Sievers, Yvette Robbins, Xinping Yang, Angel P. Huynh, Jason M. Redman +6 more

Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9

PLoS ONE(2024)10.1371/journal.pone.0287733

N/A

0DataRank · unranked

2 citations

Christine M. Minnar, Mayank Tandon, Mary R. Guest, Raj Chari, Jeffrey Schlom +2 more

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011378

N/A

0DataRank · unranked

7 citations

Maria Gracia-Hernandez, Loc Le, Masafumi Iida, James L. Gulley, Renee N. Donahue +4 more

Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-1192

N/A

0DataRank · unranked

6 citations

María del Mar Maldonado, Jeffrey Schlom, Duane H. Hamilton, Maria Gracia-Hernandez

Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013158

N/A

0DataRank · unranked

2 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Michelle R. Padget, J Lee, Clint Allen +7 more

Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1490

N/A

0DataRank · unranked

2 citations

Carolina Celades, Christine M. Minnar, Asma S. Khelifa, Lisa K. Poppe, Dara Bracken‐Clarke +8 more

Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.06.006

N/A

0DataRank · unranked

2 citations

Alon Lazarovich, Ragheed Saoud, Aaron Dahmen, Samuel Tremblay, Siobhan Telfer +20 more

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000433

N/A

0DataRank · unranked

247 citations

Sofia R. Gameiro, Caroline Jochéms, Renee N. Donahue, Julius Strauss, James L. Gulley +3 more

Therapeutic Vaccines for HPV-Associated Malignancies

ImmunoTargets and Therapy(2020)10.2147/itt.s273327

N/A

0DataRank · unranked

124 citations

Nicholas Roller, Samuel T. Pellom, Jeffrey Schlom, Caroline Jochéms, Claire Smalley Rumfield

Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000326

N/A

0DataRank · unranked

97 citations

Jeffrey Riskin, Heidi Hempel, Kristen Fousek, Hanne Lind, Duane H. Hamilton +7 more

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000612

N/A

0DataRank · unranked

78 citations

Samuel T. Pellom, Y. Maurice Morillon, Jeffrey Schlom, Caroline Jochéms, Claire Smalley

The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents

Anticancer Research(2020)10.21873/anticanres.14540

N/A

0DataRank · unranked

67 citations

Ariana Sabzevari, Jeffrey Schlom, John W. Greiner, Y. Maurice Morillon

Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000493

N/A

0DataRank · unranked

53 citations

Kristin C. Hicks, Yohei Ozawa, Jeffrey Schlom, Sofia R. Gameiro, Karin M. Knudson

Overcoming hypoxia-induced functional suppression of NK cells

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000246

N/A

0DataRank · unranked

68 citations

Michelle R. Padget, Kellsye P. Fabian, Benjamin Wolfson, Fabiola Cecchi, Todd Hembrough +6 more

Combination therapies utilizing neoepitope-targeted vaccines

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02729-y

N/A

0DataRank · unranked

22 citations

Jeffrey Schlom, Duane H. Hamilton, Karin L. Lee

Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

Cancer Immunology Research(2020)10.1158/2326-6066.cir-20-0638

N/A

0DataRank · unranked

16 citations

Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii +4 more

The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa

Frontiers in Oncology(2020)10.3389/fonc.2020.00549

N/A

0DataRank · unranked

27 citations

Claire Smalley, Samuel T. Pellom, Ariana Sabzevari, Nicholas Roller, Lucas A. Horn +5 more

The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa415

N/A

0DataRank · unranked

4 citations

Renee N. Donahue, Jeffrey Schlom

Rationale for IL-15 superagonists in cancer immunotherapy

Expert Opinion on Biological Therapy(2020)10.1080/14712598.2020.1738379

N/A

0DataRank · unranked

74 citations

James W. Hodge, Jeffrey Schlom, Sofia R. Gameiro, Karin M. Knudson

A randomized, double-blind, phase II clinical trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination with standard of care definitive radiotherapy in locally advanced, unresectable, chordoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11527

N/A

0DataRank · unranked

9 citations

Marijo Bilušić, Deric Park, Christopher R. Heery, Ravi A. Madan, Julius Strauss +7 more

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.30.926535

N/A

0DataRank · unranked

3 citations

Sarah Greene, Jay Friedman, Paúl E. Clavijo, Carter Van Waes, Kellsye P. Fabian +9 more

Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment

Molecular Oncology(2021)10.1002/1878-0261.13146

N/A

0DataRank · unranked

172 citations

Jeffrey Schlom, Mary Helen Barcellos‐Hoff, Xiao‐Jing Wang, Joan Seoane, François Audhuy +4 more

Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape

Nature Communications(2021)10.1038/s41467-021-25393-x

N/A

0DataRank · unranked

87 citations

Paul L. Chariou, Yohei Ozawa, Christine M. Minnar, Karin M. Knudson, Thomas J. Meyer +5 more

Immunology of Lynch Syndrome

Current Oncology Reports(2021)10.1007/s11912-021-01085-z

N/A

0DataRank · unranked

36 citations

Jeffrey Schlom, Danielle M. Pastor

Jeffrey Schlom

Indexed papers

Top data-sharing exemplar

Papers